Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Cancer Res. 2011 Jan 15;17(2):203-5. doi: 10.1158/1078-0432.CCR-10-2825. Epub 2010 Nov 24.

Blinded by the light: molecular imaging in pancreatic adenocarcinoma.

Author information

  • 1Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, California, USA. mtempero@medicine.ucsf.edu

Abstract

The early detection and optimal perisurgical management of pancreatic adenocarcinoma are paramount goals in our quest to increase cure rates in this lethal malignancy. Molecular imaging techniques may be the conduit through which new genomic and proteomic discoveries about this disease are brought to the clinic.

©2010 AACR.

Comment on

  • Plectin-1 as a novel biomarker for pancreatic cancer. [Clin Cancer Res. 2011]
PMID:
21106729
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk